128 related articles for article (PubMed ID: 37159051)
1. Lentinan-laden microspheres reprogram the tumor microenvironment and improve anti-PD-L1 efficacy.
Wang H; Gao XD; Yue H
J Mater Chem B; 2023 May; 11(20):4475-4484. PubMed ID: 37159051
[TBL] [Abstract][Full Text] [Related]
2. Self-assembled traditional Chinese nanomedicine modulating tumor immunosuppressive microenvironment for colorectal cancer immunotherapy.
Mao Q; Min J; Zeng R; Liu H; Li H; Zhang C; Zheng A; Lin J; Liu X; Wu M
Theranostics; 2022; 12(14):6088-6105. PubMed ID: 36168633
[TBL] [Abstract][Full Text] [Related]
3. Lentinan enhances the antitumor effects of Delta-like 1 via neutrophils.
Xu H; Qi Z; Zhao Q; Xue J; Zhu J; He Y; Liu G; Qin S
BMC Cancer; 2022 Aug; 22(1):918. PubMed ID: 36008793
[TBL] [Abstract][Full Text] [Related]
4. Lentinan inhibits tumor angiogenesis via interferon γ and in a T cell independent manner.
Deng S; Zhang G; Kuai J; Fan P; Wang X; Zhou P; Yang D; Zheng X; Liu X; Wu Q; Huang Y
J Exp Clin Cancer Res; 2018 Oct; 37(1):260. PubMed ID: 30373628
[TBL] [Abstract][Full Text] [Related]
5. [Effects of lentinan in advanced or recurrent cases of gastric, colorectal, and breast cancer].
Taguchi T
Gan To Kagaku Ryoho; 1983 Feb; 10(2 Pt 2):387-93. PubMed ID: 6349538
[TBL] [Abstract][Full Text] [Related]
6. Lentinan progress in inflammatory diseases and tumor diseases.
Zhou G; Liu H; Yuan Y; Wang Q; Wang L; Wu J
Eur J Med Res; 2024 Jan; 29(1):8. PubMed ID: 38172925
[TBL] [Abstract][Full Text] [Related]
7. Lentinan produces a robust antidepressant-like effect via enhancing the prefrontal Dectin-1/AMPA receptor signaling pathway.
Bao H; Sun L; Zhu Y; Ran P; Hu W; Zhu K; Li B; Hou Y; Nie J; Gao T; Shan L; Du K; Zheng S; Zheng B; Xiao C; Du J
Behav Brain Res; 2017 Jan; 317():263-271. PubMed ID: 27693847
[TBL] [Abstract][Full Text] [Related]
8. Randomised phase III study of S-1 alone versus S-1 plus lentinan for unresectable or recurrent gastric cancer (JFMC36-0701).
Yoshino S; Nishikawa K; Morita S; Takahashi T; Sakata K; Nagao J; Nemoto H; Murakami N; Matsuda T; Hasegawa H; Shimizu R; Yoshikawa T; Osanai H; Imano M; Naitoh H; Tanaka A; Tajiri T; Gochi A; Suzuki M; Sakamoto J; Saji S; Oka M
Eur J Cancer; 2016 Sep; 65():164-71. PubMed ID: 27501505
[TBL] [Abstract][Full Text] [Related]
9. [Scanning electron microscopic observation of mouse ascitic carcinoma cells after intraperitoneal administration of lentinan].
Kurokawa T; Tamakuma S
Nihon Gan Chiryo Gakkai Shi; 1990 Dec; 25(12):2822-7. PubMed ID: 2074392
[TBL] [Abstract][Full Text] [Related]
10. Local delivery of biocompatible lentinan/chitosan composite for prolonged inhibition of postoperative breast cancer recurrence.
Gu S; Xu J; Teng W; Huang X; Mei H; Chen X; Nie G; Cui Z; Liu X; Zhang Y; Wang K
Int J Biol Macromol; 2022 Jan; 194():233-245. PubMed ID: 34871653
[TBL] [Abstract][Full Text] [Related]
11. Preparation of lentinan-calcium carbonate microspheres and their application as vaccine adjuvants.
Liu Z; Yu L; Gu P; Bo R; Wusiman A; Liu J; Hu Y; Wang D
Carbohydr Polym; 2020 Oct; 245():116520. PubMed ID: 32718625
[TBL] [Abstract][Full Text] [Related]
12. Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.
Xiao Y; Zhu T; Zeng Q; Tan Q; Jiang G; Huang X
Acta Biomater; 2023 Feb; 157():451-466. PubMed ID: 36442821
[TBL] [Abstract][Full Text] [Related]
13. [Synergistic action of lentinan (LNT) with endocrine therapy of breast cancer in rats and humans].
Kosaka A; Kuzuoka M; Yamafuji K; Imaizumi A; Hattori Y; Yamashita A
Gan To Kagaku Ryoho; 1987 Feb; 14(2):516-22. PubMed ID: 3101609
[TBL] [Abstract][Full Text] [Related]
14. Lentinan diminishes apoptotic bodies in the ileal crypts associated with S-1 administration.
Suga Y; Takehana K
Int Immunopharmacol; 2017 Sep; 50():55-60. PubMed ID: 28628771
[TBL] [Abstract][Full Text] [Related]
15. Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist.
Knudson KM; Hicks KC; Ozawa Y; Schlom J; Gameiro SR
J Immunother Cancer; 2020 Apr; 8(1):. PubMed ID: 32303618
[TBL] [Abstract][Full Text] [Related]
16. [Anti tumor activities of lentinan and micellapist in tumor-bearing mice].
Maruyama S; Sukekawa Y; Kaneko Y; Fujimoto S
Gan To Kagaku Ryoho; 2006 Nov; 33(12):1726-9. PubMed ID: 17212088
[TBL] [Abstract][Full Text] [Related]
17. Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities.
Hack SP; Zhu AX; Wang Y
Front Immunol; 2020; 11():598877. PubMed ID: 33250900
[TBL] [Abstract][Full Text] [Related]
18. Lentinan confers protection against type 1 diabetes by inducing regulatory T cell in spontaneous non-obese diabetic mice.
Wu T; Cai Z; Niu F; Qian B; Sun P; Yang N; Pang J; Mei H; Chang X; Chen F; Zhu Y; Li Y; Wu FG; Zhang Y; Lei T; Han X
Nutr Diabetes; 2023 Apr; 13(1):4. PubMed ID: 37031163
[TBL] [Abstract][Full Text] [Related]
19. Lentinan Enhances the Function of Oxaliplatin on the Esophageal Tumors by Persuading Immunogenic Cell Death.
Huo X; Pei Z; Wang W; Liu Y; Sun J; Wang H; Ai N
Comput Math Methods Med; 2022; 2022():2296574. PubMed ID: 35844448
[TBL] [Abstract][Full Text] [Related]
20. Lentinan Inhibits Tumor Progression by Immunomodulation in a Mouse Model of Bladder Cancer.
Sun M; Bu R; Zhang B; Cao Y; Liu C; Zhao W
Integr Cancer Ther; 2020; 19():1534735420946823. PubMed ID: 32735179
[No Abstract] [Full Text] [Related]
[Next] [New Search]
